Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Rowa Y. AlhabbabDivision of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
2020en
ABI
Abstract
, the interaction between CSCs and the immune system, CAR T cell genetic engineering and signaling, CAR T cells in targeting CSCs, and the barriers in using CAR T cells as immunotherapy to treat solid cancers.
Identifiers
Citations and references
Cited by 30 references